Brown Adipose Tissue Sheds Extracellular Vesicles That Carry Potential Biomarkers of Metabolic and Thermogenesis Activity Which Are Affected by High Fat Diet Intervention.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Sep 2022
Historique:
received: 04 08 2022
revised: 09 09 2022
accepted: 13 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Brown adipose tissue (BAT) is a key target for the development of new therapies against obesity due to its role in promoting energy expenditure; BAT secretory capacity is emerging as an important contributor to systemic effects, in which BAT extracellular vesicles (EVs) (i.e., batosomes) might be protagonists. EVs have emerged as a relevant cellular communication system and carriers of disease biomarkers. Therefore, characterization of the protein cargo of batosomes might reveal their potential as biomarkers of the metabolic activity of BAT. In this study, we are the first to isolate batosomes from lean and obese Sprague-Dawley rats, and to establish reference proteome maps. An LC-SWATH/MS analysis was also performed for comparisons with EVs secreted by white adipose tissue (subcutaneous and visceral WAT), and it showed that 60% of proteins were exclusive to BAT EVs. Precisely, batosomes of lean animals contain proteins associated with mitochondria, lipid metabolism, the electron transport chain, and the beta-oxidation pathway, and their protein cargo profile is dramatically affected by high fat diet (HFD) intervention. Thus, in obesity, batosomes are enriched with proteins involved in signal transduction, cell communication, the immune response, inflammation, thermogenesis, and potential obesity biomarkers including UCP1, Glut1, MIF, and ceruloplasmin. In conclusion, the protein cargo of BAT EVs is affected by the metabolic status and contains potential biomarkers of thermogenesis activity.

Identifiants

pubmed: 36142750
pii: ijms231810826
doi: 10.3390/ijms231810826
pmc: PMC9504916
pii:
doi:

Substances chimiques

Biomarkers 0
Glucose Transporter Type 1 0
Proteome 0
Uncoupling Protein 1 0
Ceruloplasmin EC 1.16.3.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI19/00305

Références

Cell Metab. 2018 Jan 9;27(1):195-209.e6
pubmed: 29153407
J Mol Med (Berl). 2016 Nov;94(11):1241-1253
pubmed: 27394413
Mol Metab. 2018 Dec;18:134-142
pubmed: 30473096
Mol Cancer. 2016 Nov 16;15(1):71
pubmed: 27852311
Biochim Biophys Acta Proteins Proteom. 2019 Dec;1867(12):140172
pubmed: 30502511
Nutr Rev. 2012 Oct;70(10):611-21
pubmed: 23035807
J Endocrinol. 2019 Nov;243(2):R19-R27
pubmed: 31419785
Int J Obes (Lond). 2020 Mar;44(3):697-706
pubmed: 31965068
Transl Res. 2022 Jan;239:85-102
pubmed: 33465489
J Extracell Vesicles. 2019 Apr 01;8(1):1596016
pubmed: 30988894
Obesity (Silver Spring). 2014 May;22(5):1296-308
pubmed: 24339422
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377
pubmed: 32588943
Cell Rep. 2018 Oct 16;25(3):784-797.e4
pubmed: 30332656
Handb Exp Pharmacol. 2019;251:239-256
pubmed: 29675584
Diabetes. 2011 Jul;60(7):1917-25
pubmed: 21593202
J Biol Chem. 2020 May 15;295(20):7033-7045
pubmed: 32273338
Biomed Pharmacother. 2018 Jul;103:482-489
pubmed: 29677533
Cell Metab. 2009 Feb;9(2):203-9
pubmed: 19187776
Biochem J. 2022 Jun 17;479(11):1237-1256
pubmed: 35594055
Cell. 2018 Oct 18;175(3):695-708.e13
pubmed: 30293865
Sci Rep. 2017 Nov 22;7(1):16082
pubmed: 29167565
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
Sci Rep. 2015 Jul 22;5:12214
pubmed: 26198096
Z Naturforsch C J Biosci. 1996 Nov-Dec;51(11-12):859-69
pubmed: 9031527
Biochem Biophys Res Commun. 2010 Aug 6;398(4):723-9
pubmed: 20621060
Nat Rev Immunol. 2014 Mar;14(3):166-80
pubmed: 24481336
Adv Nutr. 2021 Mar 31;12(2):566-574
pubmed: 32879940
Handb Exp Pharmacol. 2019;251:337-346
pubmed: 29633182
Theranostics. 2020 Jun 12;10(16):7422-7435
pubmed: 32642003
Mol Aspects Med. 2018 Apr;60:81-91
pubmed: 29175307
Mol Cell Proteomics. 2018 Dec;17(12):2358-2370
pubmed: 30135203
Clin Biochem. 2011 Apr;44(5-6):351-6
pubmed: 21291874
Diabetes Metab J. 2021 Jan;45(1):97-108
pubmed: 32602277
Essays Biochem. 2018 May 15;62(2):165-175
pubmed: 29717059
J Clin Endocrinol Metab. 2014 Jan;99(1):E36-44
pubmed: 24178789
Cancer Res. 2016 Jul 15;76(14):4051-7
pubmed: 27216185
Physiol Rev. 2004 Jan;84(1):277-359
pubmed: 14715917
Biochem Soc Trans. 1996 Aug;24(3):893-6
pubmed: 8878870
Acta Physiol (Oxf). 2020 Feb;228(2):e13339
pubmed: 31278836
Int J Mol Sci. 2020 Mar 24;21(6):
pubmed: 32214011
J Nutr. 1983 Mar;113(3):714-20
pubmed: 6298390
J Neural Transm (Vienna). 2011 Jul;118(7):1071-7
pubmed: 21298297
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E574-E582
pubmed: 29944389
Diabetologia. 2006 Apr;49(4):744-7
pubmed: 16496121
Trends Endocrinol Metab. 2017 Jan;28(1):3-18
pubmed: 27810172
Nat Commun. 2021 Oct 27;12(1):6212
pubmed: 34707105
Diabetes. 2006 Feb;55(2):273-80
pubmed: 16443757
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
J Surg Res. 2014 Dec;192(2):268-75
pubmed: 25086727
Biochem Biophys Res Commun. 2020 Sep 24;530(3):500-507
pubmed: 32595040
J Extracell Vesicles. 2017 Apr 10;6(1):1305677
pubmed: 28473884
Int J Mol Sci. 2020 Dec 09;21(24):
pubmed: 33316953
Cell Metab. 2019 Nov 5;30(5):963-975.e7
pubmed: 31668873
J Cell Sci. 2013 May 1;126(Pt 9):1931-41
pubmed: 23444368
J Nanobiotechnology. 2021 Aug 21;19(1):250
pubmed: 34419056
Curr Opin Cell Biol. 2015 Aug;35:69-77
pubmed: 26001269
Rev Endocr Metab Disord. 2022 Feb;23(1):31-41
pubmed: 33712997
Front Physiol. 2018 Nov 23;9:1672
pubmed: 30532712
J Lipid Res. 2019 Apr;60(4):734-740
pubmed: 30705117
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
Int J Obes (Lond). 2006 Sep;30(9):1347-55
pubmed: 16534530
J Intern Med. 2018 Nov;284(5):492-504
pubmed: 29923291
N Engl J Med. 2014 Nov 20;371(21):2040-1
pubmed: 25409390
Front Endocrinol (Lausanne). 2017 Aug 18;8:202
pubmed: 28868048
Diabetes. 2009 Nov;58(11):2498-505
pubmed: 19675137
Metabolism. 2022 May;130:155159
pubmed: 35150731
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
Nat Commun. 2016 Apr 27;7:11420
pubmed: 27117818
Front Immunol. 2021 Feb 25;12:608680
pubmed: 33717092
Science. 2019 Mar 1;363(6430):989-993
pubmed: 30819964

Auteurs

Tamara Camino (T)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Nerea Lago-Baameiro (N)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Aurelio Sueiro (A)

Grupo Endocrinología Molecular y Celular, Instituto de Investigación Sanitaria de Santiago (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Susana Belén Bravo (SB)

Unidad de Proteómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Iván Couto (I)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.
Servicio de Cirugía Plástica y Reparadora, Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Francisco Fernando Santos (FF)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.
Servicio de Cirugía General, Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.

Javier Baltar (J)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Felipe F Casanueva (FF)

Grupo Endocrinología Molecular y Celular, Instituto de Investigación Sanitaria de Santiago (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

María Pardo (M)

Grupo Obesidómica, Área de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Articles similaires

Humans Meals Time Factors Female Adult
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation

Classifications MeSH